The Latest Research on ADHD

Published Online: Wednesday, April 17, 2013
Follow Pharmacy_Times:
In this podcast, which is part of the virtual AD/HD conference podcast series, Kenny Handelman, MD, discusses what is new and interesting in the world of ADHD research—and cautions against being taken in by sensational media accounts of this research. To listen to this podcast online, click here.
Related Articles
The FDA had accepted for review Tris Pharma’s New Drug Application for its extended-release liquid amphetamine to treat ADHD in children.
Children with attention-deficit/hyperactivity disorder may be more at risk for binge eating than their peers.
Even though Shire is seeking an adult indication for its investigational ADHD treatment, the FDA is requesting pediatric data before deliberating the drug’s approval.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$